16.35USD-2.76%Mkt Cap: 562.55M USDP/E: —Last update: 2026-06-01
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source …
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap562.55M USD
Enterprise Value581.07M USD
Revenue (TTM)99.53M USD
Gross Profit77.22M USD
Net Income (TTM)-21.46M USD
Revenue/Share2.991 USD
Last Price16.35 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees220
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-55.64
PEG—
EV/EBITDA-35.20
EV/Revenue5.84
P/S5.67
P/B29.17
EPS (TTM)-0.65
EPS (Forward)-0.30
52W Range
7.56373% of range19.60
52W High19.60 USD
52W Low7.563 USD
Profitability
Gross Margin77.23%
Oper. Margin-25.23%
EBITDA Margin-16.59%
Profit Margin-21.47%
ROE-112.79%
ROA-20.33%
Growth
Revenue Growth-2.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.01M USD
CapEx (TTM)332.00K USD
FCF Margin-2.75%
FCF Yield-0.49%
Net Debt16.48M USD
Net Debt/EBITDA-1.00
Balance Sheet
Debt/Equity3.72
Current Ratio5.38
Quick Ratio4.25
Book Value/Sh0.5670 USD
Cash/Share1.583 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)20.00 USD
Target Range18.00 USD – 22.00 USD
# Analysts8
Ownership
Shares Out.34.09M
Float23.36M
Insiders3.99%
Institutions96.27%
Short Interest
Short Ratio2.9d
Short % Float2.07%
Short % Out.1.80%
Shares Short613.82K
Short (prev mo.)916.81K
Technical
SMA 5015.61 (+4.8%)
SMA 20013.76 (+18.9%)
Beta1.93
S&P 52W Chg27.94%
Avg Vol (30d)194.51K
Avg Vol (10d)142.55K
Technical Indicators
RSI (14)53.4
MACD0.2215
MACD Signal0.2078
MACD Hist.+0.0137
BB Upper18.73 USD
BB Middle16.72 USD
BB Lower14.70 USD
BB Width24.08%
ATR (14)0.9121 USD
Vol Ratio (20d)0.36x